Compounds > ((2-n-butyl-6,7-dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1h-inden-5-yl)oxy)acetic acid
Page last updated: 2024-08-16

((2-n-butyl-6,7-dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1h-inden-5-yl)oxy)acetic acid and mk 473

((2-n-butyl-6,7-dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1h-inden-5-yl)oxy)acetic acid has been researched along with mk 473 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bourke, RS; Cragoe, EJ; Gould, NP; Kimelberg, HK; Nelson, LR; Popp, AJ; Sedransk, N; Waldman, JB; Woltersdorf, OW; Ziegler, C1

Other Studies

1 other study(ies) available for ((2-n-butyl-6,7-dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1h-inden-5-yl)oxy)acetic acid and mk 473

ArticleYear
Agents for the treatment of brain injury. 1. (Aryloxy)alkanoic acids.
    Journal of medicinal chemistry, 1982, Volume: 25, Issue:5

    Topics: Animals; Astrocytes; Bicarbonates; Brain Injuries; Carboxylic Acids; Cats; Cerebral Cortex; Chemical Phenomena; Chemistry; Electroencephalography; Ethacrynic Acid; In Vitro Techniques; Indans; Rats; Stereoisomerism; Structure-Activity Relationship; Time Factors

1982